Michal Vrablik Selected Research

Oxidoreductases (Dehydrogenase)

1/2011

Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michal Vrablik Research Topics

Disease

9	Atherosclerosis 10/2023 - 01/2011
9	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 08/2008
5	Dyslipidemias (Dyslipidemia) 11/2023 - 01/2011
5	Muscular Diseases (Myopathy) 06/2023 - 01/2012
5	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 05/2011
4	Inflammation (Inflammations) 01/2022 - 01/2011
3	Hypertension (High Blood Pressure) 07/2023 - 01/2021
3	Hypercholesterolemia 04/2023 - 01/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2013
3	Myocardial Infarction 01/2022 - 01/2003
3	Myalgia 12/2017 - 01/2012
2	Diabetes Mellitus 01/2021 - 05/2013
2	Thromboembolism 01/2008 - 10/2006
1	Insulin Resistance 03/2024
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 11/2023
1	Genetic Risk Score 11/2023
1	Rheumatoid Arthritis 09/2022
1	Multiple Sclerosis 06/2022
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Heart Failure 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Polymyositis 01/2022
1	Vascular Diseases (Vascular Disease) 12/2021
1	Acute Coronary Syndrome 01/2021
1	Infections 01/2020
1	COVID-19 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 12/2017
1	Injection Site Reaction 01/2017
1	Stroke (Strokes) 01/2017
1	Unstable Angina 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2013
1	Coronary Disease (Coronary Heart Disease) 01/2012
1	Osteoporosis 01/2012
1	Atrophy 01/2012
1	Frailty 01/2011
1	Weight Loss (Weight Reduction) 01/2011
1	Overweight 01/2011
1	Body Weight (Weight, Body) 01/2011

Drug/Important Bio-Agent (IBA)

11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 01/2011
11	LipidsIBA 09/2022 - 04/2016
7	oxidized low density lipoproteinIBA 10/2023 - 04/2016
4	Triglycerides (Triacylglycerol)IBA 03/2024 - 01/2003
3	LDL CholesterolIBA 03/2024 - 01/2021
3	Lipoproteins (Lipoprotein)IBA 04/2023 - 01/2011
3	CholesterolIBA 06/2022 - 01/2011
2	Apolipoproteins E (ApoE)IBA 11/2023 - 01/2011
2	ApolipoproteinsIBA 11/2023 - 01/2003
2	Fenofibrate (CiL)FDA LinkGeneric 01/2021 - 04/2016
2	EnzymesIBA 12/2017 - 01/2011
2	coenzyme Q10 (CoQ10)IBA 12/2017 - 01/2012
2	Atorvastatin (Lipitor)FDA Link 12/2017 - 01/2012
2	HDL CholesterolIBA 05/2013 - 05/2011
1	C-Reactive ProteinIBA 03/2024
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2024
1	Apolipoprotein E2IBA 11/2023
1	Small Interfering RNA (siRNA)IBA 04/2023
1	ALN-PCSIBA 04/2023
1	Proprotein Convertase 9IBA 01/2022
1	Ezetimibe (Zetia)FDA Link 01/2022
1	IncretinsIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Apolipoprotein B-100 (Apo B 100)IBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	InterleukinsIBA 12/2021
1	canakinumab FDA Link 12/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Simvastatin (Zocor)FDA LinkGeneric 12/2017
1	bococizumabIBA 01/2017
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2015
1	Estrogens (Estrogen)FDA Link 01/2012
1	Oxidoreductases (Dehydrogenase)IBA 01/2011
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2011
1	glutaryl-coenzyme A (glutaryl-CoA)IBA 01/2011
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 10/2006

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2012
3	Secondary Prevention 07/2023 - 01/2012
3	Estrogen Replacement Therapy 08/2008 - 10/2006
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2012 - 08/2008
1	Cutaneous Administration 10/2006